News >

Sequencing Challenges Emerge in Myeloma as Options Expand

Kristi Rosa
Published: Monday, Apr 22, 2019

Omar Nadeem, MD

Omar Nadeem, MD

As more novel agents are added to the treatment paradigm for relapsed/refractory multiple myeloma, Omar Nadeem, MD, stressed that the big challenge lies in determining how best to sequence these therapies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication